1Smolarek TA, Wessner LL, McCormack FX, et al. Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis. Am J Hum Genet, 1998,62:810-815.
2Boehler A, Speich R, Russi EW, et al. Lung transplantation for lymphangioleiomyomatosis. N Engl J Med, 1996,335:1275-1280.
3de Perrot M, Licker M, Robert J, et al. Successful combined lung and kidney transplantation for pulmonary lymphangioleiomyomatosis and renal angiolipomas. Eur Respir J, 1998,12:1479-1481.
4Karbowniczek M, Astrinidis A, Balsara BR, et al. Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism. Am J Respir Crit Care Med, 2003,167:976-982.
5Grossi P, Farina C, Fiocchi R, et al. Prevalence and outcome of invasive fungal infections in 1,963 thoracic organ transplant recipients: a multicenter retrospective study. Italian Study Group of Fungal Infections in Thoracic Organ Transplant Recipients. Transplantation, 2000,70:112-116.
6Herrera JM, McNeil KD, Higgins RS, et al. Airway complications after lung transplantation: treatment and long-term outcome. Ann Thorac Surg,2001,71:989-993.
7Calvo V, Borro JM, Morales P, et al. Antifungal prophylaxis during the early postoperative period of lung transplantation. Chest, 1999,115:1301-1304.
8Hunstad DA, Cohen AH, St Geme JW 3rd. Successful eradication of mucormycosis occurring in a pulmonary allograft. J Heart Lung Transplant, 1999,18:801-804.
